The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand
Abstract
✓ Tirilazad mesylate, a nonglucocorticoid 21-aminosteroid, has been shown in experimental models to reduce vasospasm following subarachnoid hemorrhage (SAH) and to reduce infarct size from focal cerebral ischemia. To test whether treatment with tirilazad would reduce ischemic symptoms from vasospasm and improve overall outcome in patients with ruptured aneurysms, a prospective randomized, double-blind, vehicle-controlled trial was conducted at 41 neurosurgical centers in Europe, Australia, and New Zealand. One thousand twenty-three patients were randomly assigned to receive 0.6, 2, or 6 mg/kg per day of intravenously administered tirilazad or a placebo containing the citrate vehicle. All patients were also treated with intravenously administered nimodipine. Patients receiving 6 mg/kg per day of tirilazad had reduced mortality (p = 0.01) and a greater frequency of good recovery on the Glasgow Outcome Scale 3 months after SAH (p = 0.01) than similar patients treated with vehicle. There was a reduction in symptomatic vasospasm in the group that received 6 mg/kg per day tirilazad; however, the difference was not statistically significant (p = 0.048). The benefits of treatment with tirilazad were predominantly shown in men rather than in women. There were no material differences between the outcomes in the groups treated with 0.6 and 2 mg/kg tirilazad per day and the group treated with vehicle. Tirilazad was well tolerated at all three dose levels. These observations suggest that tirilazad mesylate, at a dosage of 6 mg/kg per day, is safe and improves overall outcome in patients (especially in men) who have experienced an aneurysmal SAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Neter, J., Wasserman, W., & Kutner, M. (1990) · Cited by 1,564
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
Self-citation(1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0985 · Cited by 1,196
Haley, E. C., Kassell, N. F., Torner, J. C., & _, _. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.4.0537 · Cited by 351
Self-citationFree radicals in central nervous system ischemia.
Schmidley, J. W. (1990) · Stroke · doi:10.1161/01.str.21.7.1086 · Cited by 256
Hall, E. D., McCall, J. M., & Means, E. D. (1994) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60497-4 · Cited by 211
Xue, D., Slivka, A. P., & Buchan, A. M. (1992) · Stroke · doi:10.1161/01.str.23.6.894 · Cited by 147
Haley, E. C., Kassell, N. F., Torner, J. C., Truskowski, L. L., Germanson, T. P., & _, _. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.5.0788 · Cited by 142
Self-citationPhase II trial of tirilazad in aneurysmal subarachnoid hemorrhage
Haley, E. C., Kassell, N. F., Alves, W. M., Weir, B., Apperson-Hansen, C., & _, _. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.5.0786 · Cited by 126
Self-citationEffect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage
Zuccarello, M., Marsch, J. T., Schmitt, G., Woodward, J., & Anderson, D. K. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.71.1.0098 · Cited by 105
Park, C. K., & Hall, E. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91649-7 · Cited by 76
Prognosis of patients with severe head injury
Jennett, B., Teasdale, G. M., Braakman, R., Minderhoud, J. M., Heiden, J. S., & Kurze, T. (1979) · Neurosurgery · doi:10.1097/00006123-197904000-00001 · Cited by 65
Fleishaker, J. C., Peters, G. R., & Cathcart, K. S. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03940.x · Cited by 57
The Effect of the 21-Aminosteroid U74006F in a Rabbit Model of Thromboembolic Stroke
Wilson, J. T., Bednar, M. M., McAuliffe, T. L., Raymond, S. J., & Gross, C. E. (1992) · Neurosurgery · doi:10.1097/00006123-199211000-00016 · Cited by 36
Fleishaker, J. C., Peters, G. R., Cathcart, K. S., & Steenwyk, R. C. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03941.x · Cited by 34
Fleishaker, J. C., Pearson, L. K., & Peters, G. R. (1995) · American Journal of Therapeutics · doi:10.1097/00045391-199508000-00007 · Cited by 28
Cited by
Connolly, E. S., Rabinstein, A. A., Carhuapoma, J. R., Derdeyn, C. P., Dion, J., Higashida, R. T., Hoh, B. L., Kirkness, C. J., Naidech, A. M., Ogilvy, C. S., et al. (2012) · Stroke · doi:10.1161/str.0b013e3182587839 · Cited by 3,512
Subarachnoid haemorrhage: diagnosis, causes and management
van Gijn, J., & Rinkel, G. J. E. (2001) · Brain · doi:10.1093/brain/124.2.249 · Cited by 1,353
Bederson, J. B., Connolly, E. S., Batjer, H. H., Dacey, R. G., Dion, J. E., Diringer, M. N., Duldner, J. E., Harbaugh, R. E., Patel, A. B., & Rosenwasser, R. H. (2009) · Stroke · doi:10.1161/strokeaha.108.191395 · Cited by 1,189
Prediction of Symptomatic Vasospasmafter Subarachnoid Hemorrhage: The Modified Fisher Scale
Frontera, J. A., Claassen, J., Schmidt, J. M., Wartenberg, K. E., Temes, R., Connolly, E. S., Macdonald, R. L., & Mayer, S. A. (2006) · Neurosurgery · doi:10.1227/01.neu.0000218821.34014.1b · Cited by 844
Oxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Metadata
- Authors
- Kassell, N. F., Haley, E. C., Apperson-Hansen, C., Alves, W. M., & _, _.
- Venue
- Journal of Neurosurgery
- Published
- 1996-02
- Volume
- 84
- Issue
- 2
- Pages
- 221-228
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2098798964
- Cited by
- 394
- References
- 17
- FWCI
- 28.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.